136 related articles for article (PubMed ID: 26906104)
21. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
22. [Studies on the fine stereostructure of taxoids].
Wu N; Lu Y; Zheng Q; Fang W; Gao Y; Fang Q; Zhou T
Yao Xue Xue Bao; 1998 Oct; 33(10):759-63. PubMed ID: 12016929
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the chemistry of taxol.
Kingston DG
J Nat Prod; 2000 May; 63(5):726-34. PubMed ID: 10843603
[TBL] [Abstract][Full Text] [Related]
24. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
Springate CM; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
[TBL] [Abstract][Full Text] [Related]
26. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel (taxotere) in the treatment of prostate cancer.
Beer TM; El-Geneidi M; Eilers KM
Expert Rev Anticancer Ther; 2003 Jun; 3(3):261-8. PubMed ID: 12820771
[TBL] [Abstract][Full Text] [Related]
28. Efficient synthesis of the 3'-phenolic metabolite of paclitaxel.
Krishna Reddy SH; Lee S; Datta A; Georg GI
J Org Chem; 2001 Nov; 66(24):8211-4. PubMed ID: 11722227
[No Abstract] [Full Text] [Related]
29. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the medicinal chemistry of taxoids with novel beta-amino acid side chains.
Ojima I; Lin S; Wang T
Curr Med Chem; 1999 Oct; 6(10):927-54. PubMed ID: 10519906
[TBL] [Abstract][Full Text] [Related]
31. Taxane analogues against breast cancer: a quantitative structure-activity relationship study.
Verma RP; Hansch C
ChemMedChem; 2008 Apr; 3(4):642-52. PubMed ID: 18196507
[TBL] [Abstract][Full Text] [Related]
32. Preclinical evaluation of docetaxel (Taxotere).
Lavelle F; Bissery MC; Combeau C; Riou JF; Vrignaud P; André S
Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer.
Bonomi P
Expert Rev Anticancer Ther; 2007 Apr; 7(4):415-22. PubMed ID: 17428162
[TBL] [Abstract][Full Text] [Related]
34. The taxanes: an update.
Crown J; O'Leary M
Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
[TBL] [Abstract][Full Text] [Related]
35. Taxanes in combined-modality therapy for solid tumors.
Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
[TBL] [Abstract][Full Text] [Related]
36. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.
Rowinsky EK
Annu Rev Med; 1997; 48():353-74. PubMed ID: 9046968
[TBL] [Abstract][Full Text] [Related]
37. [Synthesis and structure-activity relationships of novel 14 beta-side chain taxol derivatives].
Liu R; Yin D; Wang D; Li C; Guo J; Liang X
Yao Xue Xue Bao; 1998 Dec; 33(12):910-8. PubMed ID: 12016856
[TBL] [Abstract][Full Text] [Related]
38. The design and synthesis of guanosine compounds with in vitro activity against the colon cancer cell line SW480: non-taxane derived mimics of taxol?
Howarth J; Kenny P; McDonnell S; O'Connor A
Bioorg Med Chem Lett; 2003 Aug; 13(16):2693-7. PubMed ID: 12873496
[TBL] [Abstract][Full Text] [Related]
39. Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy.
Yang D; Liu X; Jiang X; Liu Y; Ying W; Wang H; Bai H; Taylor WD; Wang Y; Clamme JP; Co E; Chivukula P; Tsang KY; Jin Y; Yu L
J Control Release; 2012 Jul; 161(1):124-31. PubMed ID: 22521595
[TBL] [Abstract][Full Text] [Related]
40. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Mazzo DJ; Nguyen-Huu JJ; Pagniez S; Denis P
Am J Health Syst Pharm; 1997 Mar; 54(5):566-9. PubMed ID: 9066868
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
